Dermata Therapeutics to effect 1-for-10 reverse stock split effective August 1, 2025

Dermata Therapeutics, Inc.

Reverse stock split at 1:10 ratio effective 12:01 a.m. ET on August 1, 2025.
Every ten outstanding common shares convert to one share; no fractional shares (cash in lieu).
CUSIP changes to 249845504; trading on Nasdaq on split-adjusted basis expected August 1.
Board authorized split ratio range of 1:2 to 1:30 at July 15 annual meeting; Board selected 1:10.
Outstanding stock options and warrants will be adjusted proportionally.

item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.